ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.940
+0.040 (2.11%)
At close: Sep 11, 2026, 4:00 PM EDT
1.970
+0.030 (1.55%)
After-hours: Sep 11, 2026, 7:30 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $268.26 million as of September 11, 2026. Its market cap has increased by 328.15% in one year.
Market Cap
268.26M
Enterprise Value
141.07M
1-Year Change
328.15%
Ranking
Category
Stock Price
$1.94
ChartMarket Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $268.26M, a decrease of -74.61%. That is a compound annual growth rate of -19.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 268.26M | 337.85% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 281.28M |
| Sutro Biopharma | 279.56M |
| Fate Therapeutics | 276.79M |
| Immuneering | 276.26M |
| AC Immune | 274.42M |
| Bicycle Therapeutics | 270.17M |
| Pyxis Oncology | 267.74M |
| Camp4 Therapeutics | 266.70M |